 Tristan Huie
Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 11 | 2025 | 658 | 1.670 |
Why?
| | Lung Diseases, Interstitial | 12 | 2025 | 654 | 1.520 |
Why?
| | Hemoptysis | 2 | 2023 | 37 | 1.010 |
Why?
| | Pulmonary Medicine | 1 | 2025 | 83 | 0.870 |
Why?
| | Clinical Competence | 4 | 2025 | 1205 | 0.780 |
Why?
| | Fellowships and Scholarships | 1 | 2025 | 323 | 0.700 |
Why?
| | Simulation Training | 1 | 2023 | 127 | 0.700 |
Why?
| | Curriculum | 2 | 2025 | 1039 | 0.680 |
Why?
| | Education, Medical | 1 | 2023 | 271 | 0.650 |
Why?
| | Tomography, X-Ray Computed | 7 | 2025 | 2765 | 0.650 |
Why?
| | Education, Medical, Graduate | 1 | 2025 | 526 | 0.650 |
Why?
| | Pulmonary Fibrosis | 4 | 2025 | 399 | 0.550 |
Why?
| | Alveolitis, Extrinsic Allergic | 4 | 2019 | 93 | 0.450 |
Why?
| | Physicians | 1 | 2023 | 942 | 0.440 |
Why?
| | Arthritis, Rheumatoid | 4 | 2017 | 1178 | 0.400 |
Why?
| | Emphysema | 1 | 2013 | 116 | 0.380 |
Why?
| | Clinical Trials as Topic | 1 | 2015 | 1057 | 0.320 |
Why?
| | Smoking | 2 | 2017 | 1603 | 0.260 |
Why?
| | Bronchoscopy | 2 | 2025 | 226 | 0.250 |
Why?
| | Anatomy | 1 | 2024 | 29 | 0.220 |
Why?
| | Connective Tissue Diseases | 3 | 2013 | 85 | 0.210 |
Why?
| | Patient Acuity | 1 | 2024 | 47 | 0.210 |
Why?
| | Endosonography | 1 | 2024 | 153 | 0.200 |
Why?
| | Delphi Technique | 1 | 2025 | 313 | 0.200 |
Why?
| | Virtual Reality | 1 | 2024 | 74 | 0.200 |
Why?
| | Humans | 31 | 2025 | 141754 | 0.190 |
Why?
| | Surveys and Questionnaires | 3 | 2025 | 5974 | 0.190 |
Why?
| | Teaching Rounds | 1 | 2024 | 73 | 0.190 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2025 | 650 | 0.190 |
Why?
| | Workload | 1 | 2024 | 166 | 0.180 |
Why?
| | Vital Capacity | 6 | 2025 | 306 | 0.180 |
Why?
| | Equipment Design | 1 | 2023 | 525 | 0.180 |
Why?
| | Lung | 6 | 2019 | 4137 | 0.170 |
Why?
| | Male | 23 | 2025 | 70179 | 0.160 |
Why?
| | Female | 23 | 2025 | 75943 | 0.150 |
Why?
| | Radiologists | 1 | 2019 | 52 | 0.150 |
Why?
| | Cause of Death | 2 | 2019 | 441 | 0.150 |
Why?
| | Computer Simulation | 1 | 2023 | 1015 | 0.150 |
Why?
| | Sarcoidosis | 2 | 2011 | 163 | 0.150 |
Why?
| | Biomarkers | 1 | 2010 | 4190 | 0.150 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2019 | 110 | 0.140 |
Why?
| | Lung Transplantation | 2 | 2020 | 322 | 0.140 |
Why?
| | Intensive Care Units | 1 | 2024 | 871 | 0.140 |
Why?
| | Mortality | 1 | 2019 | 359 | 0.130 |
Why?
| | Toll-Like Receptors | 1 | 2017 | 189 | 0.120 |
Why?
| | Common Variable Immunodeficiency | 1 | 2016 | 30 | 0.120 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 437 | 0.120 |
Why?
| | Granuloma | 1 | 2016 | 97 | 0.120 |
Why?
| | Aged | 14 | 2025 | 24746 | 0.120 |
Why?
| | RNA Splicing | 1 | 2017 | 270 | 0.120 |
Why?
| | Cognition | 1 | 2024 | 1228 | 0.120 |
Why?
| | Forced Expiratory Volume | 2 | 2015 | 484 | 0.120 |
Why?
| | Middle Aged | 16 | 2025 | 34647 | 0.120 |
Why?
| | Alternative Splicing | 1 | 2017 | 232 | 0.120 |
Why?
| | Radiographic Image Enhancement | 1 | 2015 | 57 | 0.110 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1502 | 0.110 |
Why?
| | Medical History Taking | 1 | 2015 | 117 | 0.110 |
Why?
| | Leukocytes, Mononuclear | 1 | 2017 | 574 | 0.110 |
Why?
| | Survival Analysis | 3 | 2017 | 1320 | 0.110 |
Why?
| | Registries | 2 | 2020 | 2144 | 0.110 |
Why?
| | Radiography, Thoracic | 1 | 2015 | 179 | 0.100 |
Why?
| | Bronchiolitis Obliterans | 1 | 2013 | 65 | 0.100 |
Why?
| | Mycophenolic Acid | 1 | 2013 | 118 | 0.090 |
Why?
| | Bronchial Diseases | 1 | 2012 | 37 | 0.090 |
Why?
| | Lymphatic Vessels | 1 | 2012 | 64 | 0.090 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2013 | 369 | 0.090 |
Why?
| | Pulmonary Diffusing Capacity | 3 | 2017 | 76 | 0.090 |
Why?
| | Respiratory Function Tests | 4 | 2014 | 560 | 0.090 |
Why?
| | Peptides, Cyclic | 1 | 2012 | 266 | 0.080 |
Why?
| | Collagen | 1 | 2012 | 460 | 0.080 |
Why?
| | Gastroesophageal Reflux | 1 | 2012 | 244 | 0.080 |
Why?
| | RNA, Messenger | 1 | 2017 | 2828 | 0.080 |
Why?
| | Severity of Illness Index | 2 | 2019 | 2903 | 0.080 |
Why?
| | Pulmonary Embolism | 1 | 2011 | 239 | 0.070 |
Why?
| | Aged, 80 and over | 5 | 2012 | 7923 | 0.070 |
Why?
| | United States | 8 | 2020 | 15310 | 0.070 |
Why?
| | Kaplan-Meier Estimate | 3 | 2015 | 910 | 0.070 |
Why?
| | Immunosuppressive Agents | 1 | 2013 | 855 | 0.070 |
Why?
| | Multivariate Analysis | 3 | 2016 | 1498 | 0.070 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2012 | 317 | 0.070 |
Why?
| | Fibroblasts | 1 | 2012 | 1021 | 0.070 |
Why?
| | Acute Lung Injury | 1 | 2010 | 304 | 0.060 |
Why?
| | Disease Progression | 3 | 2020 | 2800 | 0.060 |
Why?
| | Respiratory Insufficiency | 1 | 2010 | 325 | 0.060 |
Why?
| | Biopsy | 3 | 2014 | 1083 | 0.060 |
Why?
| | Survival Rate | 3 | 2015 | 1972 | 0.060 |
Why?
| | Retrospective Studies | 5 | 2025 | 16374 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2020 | 1268 | 0.050 |
Why?
| | Autoantibodies | 1 | 2012 | 1475 | 0.050 |
Why?
| | Signal Transduction | 1 | 2017 | 5169 | 0.050 |
Why?
| | Cohort Studies | 3 | 2025 | 5815 | 0.050 |
Why?
| | ROC Curve | 1 | 2025 | 590 | 0.050 |
Why?
| | Cross-Over Studies | 1 | 2024 | 582 | 0.050 |
Why?
| | Radiography | 2 | 2016 | 844 | 0.050 |
Why?
| | Case-Control Studies | 3 | 2016 | 3597 | 0.050 |
Why?
| | Sex Distribution | 2 | 2012 | 381 | 0.040 |
Why?
| | Genomics | 1 | 2025 | 815 | 0.040 |
Why?
| | Occupations | 1 | 2019 | 50 | 0.040 |
Why?
| | Risk Factors | 4 | 2016 | 10482 | 0.040 |
Why?
| | Observational Studies as Topic | 1 | 2019 | 124 | 0.040 |
Why?
| | Logistic Models | 2 | 2016 | 2092 | 0.040 |
Why?
| | Biological Specimen Banks | 1 | 2019 | 99 | 0.040 |
Why?
| | Forecasting | 1 | 2019 | 384 | 0.030 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2017 | 45 | 0.030 |
Why?
| | Prognosis | 2 | 2017 | 4080 | 0.030 |
Why?
| | Hypersplenism | 1 | 2016 | 8 | 0.030 |
Why?
| | Leukopenia | 1 | 2016 | 31 | 0.030 |
Why?
| | RNA Precursors | 1 | 2017 | 156 | 0.030 |
Why?
| | Rheumatoid Factor | 1 | 2017 | 177 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2014 | 2938 | 0.030 |
Why?
| | Arthritis | 1 | 2016 | 104 | 0.030 |
Why?
| | Comorbidity | 1 | 2019 | 1664 | 0.030 |
Why?
| | Prospective Studies | 2 | 2020 | 7777 | 0.030 |
Why?
| | Internship and Residency | 1 | 2024 | 1240 | 0.030 |
Why?
| | Alberta | 1 | 2013 | 25 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor D | 1 | 2012 | 13 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor C | 1 | 2012 | 17 | 0.020 |
Why?
| | Lymphangiogenesis | 1 | 2012 | 27 | 0.020 |
Why?
| | Patient Dropouts | 1 | 2013 | 65 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 117 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 557 | 0.020 |
Why?
| | Databases, Factual | 1 | 2016 | 1448 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 521 | 0.020 |
Why?
| | Age Distribution | 1 | 2011 | 397 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2012 | 554 | 0.020 |
Why?
| | Adult | 4 | 2016 | 39391 | 0.020 |
Why?
| | Cytokines | 1 | 2017 | 2100 | 0.020 |
Why?
| | Risk | 1 | 2011 | 907 | 0.020 |
Why?
| | Exercise | 1 | 2020 | 2112 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2008 | 309 | 0.020 |
Why?
| | Chronic Disease | 1 | 2013 | 1820 | 0.020 |
Why?
| | Sex Factors | 1 | 2013 | 2063 | 0.020 |
Why?
| | Inflammation | 1 | 2017 | 2902 | 0.020 |
Why?
| | Acute Disease | 1 | 2008 | 1010 | 0.010 |
Why?
| | Young Adult | 2 | 2012 | 13749 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2013 | 5212 | 0.010 |
Why?
| | Time Factors | 1 | 2013 | 6966 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 22130 | 0.010 |
Why?
|
|
Huie's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|